When a stock hits a fresh low, it can either signal a dirt cheap dream stock or a dreadful stock to avoid. Separating the wheat from the chaff is difficult, but finding well-run companies at bargain-basement prices is a great way to accumulate a fortune over the long run.

With that in mind, we'll use the aggregate intelligence of the 135,000-plus investors participating in Motley Fool CAPS to see what the community is saying about stocks hitting 52-week lows today. The community's approval (signified by four- and five-star ratings) could indicate that further research is in order.

Here are two such stocks:

Company

Today’s Intraday Price

Industry

CAPS Rating (out of 5)

Fools Saying Outperform

UltraShort Real Estate ProShares (NYSE:SRS)

$14.88

Capital Markets

2 Stars

1038 of 1203

Genzyme Corp (NASDAQ:GENZ)

$49.95

Biotechnology

4 Stars

554 of 575

Source: Motley Fool CAPS, as of August 3, 2009

Top-rated capital markets companies:

  • POWERSHS DB MULTI SECT COMM (NYSE:DBP): Stock price is 1% lower than last year.
  • WisdomTree India Earnings Fund (NYSE:EPI): Stock price is 2% lower than last year.

Top-rated biotechnology companies:

  • Crucell N.V. (ADR) (NASDAQ:CRXL): Stock price is 48% higher than last year.
  • Sinovac Biotech Ltd. (AMEX:SVA): Stock price is 39% higher than last year.

Join us on CAPS to learn more about these and countless other interesting stock ideas.